chartexchange

LYRA
LYRA THERAPEUTICS INC
stockOTC

EODOct 2, 2026
0.15USD0.000%(0.00)348
Loading…
Loading…
266,232
Healthcare
Biotechnology
HQ
Watertown, MA, USA
Previous Close
$0.15
Beta
10.34
52-Week High
$8.75 2025-10-06
52-Week Low
$0.00 2026-08-20
SMA 50
$0.33
SMA 200
$1.41
Avg. Vol 10D
984
Avg. Vol 30D
1,243
Avg. Vol 90D
9,283
Relative Vol
0.28
1.63M
278
May 28, 2025 · 1-for-50 (reverse)
LYRA Profile

lyra therapeutics, inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. the company's xtreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. its product candidates include lyr-210 and lyr-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. the company was formerly known as 480 biomedical, inc. and changed its name to lyra therapeutics, inc. in july 2018. lyra therapeutics, inc. was founded in 2005 and is headquartered in watertown, massachusetts.

LYRA Performance
PeriodPriceDateChangeBeta
1W0.032026-09-30+400.00%-712.748
1M0.192026-09-08-21.05%45.569
3M0.602026-07-07-75.00%143.903
6M0.492026-04-06-69.41%25.623
1Y8.092025-10-06-98.15%10.343
2Y11.872024-10-04-98.74%—
5Y458.002021-10-05-99.97%1.309
LYRA Stock Summary

LYRA THERAPEUTICS INC (OTC:LYRA) stock price today is $0.15, and today's volume is 348. LYRA is up 0.000% today. The 30 day average volume is 1,243. LYRA market cap is $266,232 with 1.77M shares outstanding.